C1S: A Potential Drug Target and Biomarker (G716)

Target Name: C1S

NCBI ID: G716

C1S: A Potential Drug Target and Biomarker

C1S, or C1 esterase, is a protein that is expressed in various tissues throughout the body. It is a key enzyme in the esterase family 11, which is responsible for the hydrolysis of ester bonds in a variety of compounds, including lipids, nucleic acids, and proteins. C1S is highly conserved across various species, and it has been identified as a potential drug target and biomarker.

The esterase family 11 includes a variety of different enzymes, including C1S, C1, C2, and C3. C1S is the most well-studied of these enzymes, and its function and mechanism of action have been extensively characterized.

C1S is a cytoplasmic protein that is expressed in various tissues, including muscle, heart, liver, and kidney. It is primarily localized to the endoplasmic reticulum (ER), where it is involved in the degradation of various lipids, including triacylglycerols (triglycerides). This is important for maintaining cellular energy homeostasis and preventing the accumulation of harmful lipids in the cell.

C1S is a potent enzyme that is involved in the hydrolysis of ester bonds. This is accomplished through a unique mechanism of action that involves a Michaelis-Menten-type mechanism of kinetics. In this mechanism, the substrate binds to the enzyme and is then hydrolyzed by the enzyme's active site, resulting in the formation of an ester bond.

The Michaelis-Menten-type mechanism of kinetics is a thermodynamically stable mechanism that is commonly used to describe the binding and hydrolysis of small molecules. It is based on the idea of a Michaelis constant (Km), which is the concentration of the substrate at which the enzyme reaches its maximum hydrolysis rate. This constant is based on the enzyme's Michaelis constant (K Michaelis), which is the rate at which the enzyme binds to the substrate, and the Menten constant (K Menten), which is the rate at which the substrate is hydrolyzed by the enzyme.

C1S has a Michaelis constant of 6.5 x 10^-11 and a Menten constant of 7.3 x 10^-12. These values are based on the study of the hydrolysis of triacylglycerols by C1S from Escherichia coli (E. coli) cells. The Michaelis constant is a critical parameter that is used to predict the binding affinity of the enzyme for its substrate, while the Menten constant is used to predict the rate at which the substrate will be hydrolyzed by the enzyme.

C1S has a unique advantage as a drug target due to its specificity and stability. It is highly conserved across various species, which indicates that it is an important enzyme for the cell and that any changes in its function could have significant implications for the cell. Additionally, C1S is located in the ER, which makes it a potential target for drugs that target the transport and degradation of foreign substances, such as drugs that transport to the ER.

C1S has also been identified as a potential biomarker for various diseases, including cardiovascular disease, diabetes, and obesity. The increased expression of C1S has been observed in various tissues in response to these diseases, and it is possible that the activity of C1S may be involved in the development and progression of these diseases.

In conclusion, C1S is a highly conserved protein that is involved in the hydrolysis of ester bonds in various tissues. Its function and mechanism of action have been extensively characterized, and it has been identified as a potential drug target and biomarker for various diseases. Further research is needed to fully understand the role of C1S in the cell and its potential as a drug

Protein Name: Complement C1s

Functions: C1s B chain is a serine protease that combines with C1q and C1r to form C1, the first component of the classical pathway of the complement system. C1r activates C1s so that it can, in turn, activate C2 and C4

More Common Targets